Other personnel changes come at Lectra and G2 Goldfields
US digital healthcare company Kestra Medical Technologies has appointed Neil Bhalodkar as vice president of IR, with the position effective March 3, 2025.
Most recently, he ran the IR function at Inari Medical until its takeover by Stryker. Previously, he built and ran the IR program at Axonics, which was later acquired by Boston Scientific.
In total, Bhalodkar has more than 20 years of experience across IR, corporate finance and equity research roles.
‘On behalf of all of Kestra and its stakeholders, I am delighted to welcome Neil to the team . . .
Log in FOR FREE to access this content
Log in or create your free My IR – Essentials account to:
- Access 50+ deep dives and best practice reports
- View 100+ news analyses and our exclusive CFO series
- Instantly benchmark your IR program with our new tool
- Save favorites and get tailored content delivered to your dashboard
- 10% off all IR forums!
Join now to make a real impact in your organization.
